BPC-157 is supplied as a lyophilized powder for laboratory research use only
It completed Phase 2 trials in obesity [3] and type 2 diabetes [4] and moved into a Phase 3 program (TRIUMPH)
A common protocol, for example, is to begin with about 20 mg of NAD+ (corresponding to a small volume from the vial, typically around 0.1 mL depending on concentration) administered subcutaneously and gradually increase the dose over subsequent injections up to around 100 mg per injection
Gentle swirling rather than vortexing is recommended to avoid peptide denaturation from shear forces
The main benefit of methyl B12 over adenosyl B12 is that it comes with the methyl donor
The synergy of BPC, KPV and PEA, offers a comprehensive approach often used to support inflammation, gut health, and conditions such as Inflammatory Bowel Disease ( IBD )